Morgens Waterfall Vintiadis & Co Inc / ALNY
Morgens Waterfall Vintiadis & Co Inc’s Alnylam Pharmaceuticals Inc Position
Does Morgens Waterfall Vintiadis & Co Inc own Alnylam Pharmaceuticals Inc (ALNY)? Not currently — the last reported position was 4.0K shares worth $1M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1M
Q1 2025
Shares
4.0K
% of Portfolio
+1.22%
Quarters Held
1
position exited
Position History ALNY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 4.0K | $1M | +1.22% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Morgens Waterfall Vintiadis & Co Inc’s full portfolio or all institutional holders of ALNY.